Pungolino, E., D'Adda, M., Perego, A., Orlandi, E., Turrini, M., Borin, L., et al. (2017). Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia. Intervento presentato a: 59th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 09-12, 2017, Atlanta, GA.

Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia

Cairoli, R
2017

paper
Hematology
English
59th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 09-12, 2017
2017
2017
130
S1
2889
none
Pungolino, E., D'Adda, M., Perego, A., Orlandi, E., Turrini, M., Borin, L., et al. (2017). Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia. Intervento presentato a: 59th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 09-12, 2017, Atlanta, GA.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409615
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact